Beijing Tiantan Biological Products (SHSE:600161) Change In Receivables : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 1998. Start your Free Trial

What is Beijing Tiantan Biological Products Change In Receivables?

Beijing Tiantan Biological Products's change in receivables for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Beijing Tiantan Biological Products's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Beijing Tiantan Biological Products's change in receivables for the fiscal year that ended in Dec. 2023 was ¥1,029 Mil. It means Beijing Tiantan Biological Products's Accounts Receivable declined by ¥1,029 Mil from Dec. 2022 to Dec. 2023 .

Beijing Tiantan Biological Products's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥20 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Beijing Tiantan Biological Products's Days Sales Outstanding for the three months ended in Mar. 2024 was 1.50.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Beijing Tiantan Biological Products's liquidation value for the three months ended in Mar. 2024 was ¥4,698 Mil.

Beijing Tiantan Biological Products Change In Receivables Historical Data

The historical data trend for Beijing Tiantan Biological Products's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Tiantan Biological Products Change In Receivables Chart

Beijing Tiantan Biological Products Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-217.09

-82.48

-351.21

-221.05

1,029.48

Beijing Tiantan Biological Products Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Beijing Tiantan Biological Products Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Beijing Tiantan Biological Products (SHSE:600161) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Beijing Tiantan Biological Products's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	20.069	/	1221.955	*	91
=	1.50

2. In Ben Graham's calculation of liquidation value, Beijing Tiantan Biological Products's accounts receivable are only considered to be worth 75% of book value:

Beijing Tiantan Biological Products's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	4748.889	-	1605.335	+	0.75 * 20.069	+	0.5 * 3078.356
=	4,698

Beijing Tiantan Biological Products Change In Receivables Related Terms

Thank you for viewing the detailed overview of Beijing Tiantan Biological Products's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Tiantan Biological Products (SHSE:600161) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Tiantan Biological Products Corp Ltd (SHSE:600161) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

No. 4 Sanjianfang South Li, Zhongdan Center, Beijing, CHN, 100024

Website

http://www.tiantanbio.com

Beijing Tiantan Biological Products Corp Ltd is a China-based company engaged in the research and development, manufacturing, sales and consulting services for blood products. The company's blood products include Shanghai Blood Human Albumin, Shanghai blood system intravenous injection of human immunoglobulin, Guizhou blood human albumin, Rongsheng human albumin, Guizhou blood system static injection immunoglobulin, Rongsheng tetanus human immunoglobulin and others.

Executives

Wang Jian Ming	Supervisors
Liu Ya Na	Directors, senior managers
Fu Dao Xing	Directors, senior managers
He Yan Lin	Directors, senior managers
Hu Li Gang	Director
Ci Xiang	senior management
Yang Hui Chuan	Director
Zhang Yi	senior management
Wu Zhen Shan	senior management

Beijing Tiantan Biological Products (SHSE:600161) Headlines

No Headlines